The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

Once a week, Sun Kai has a video call with his mother, and they discuss his day-to-day life. But Sun’s mother died five years ...

Morgan Stanley lowered the firm’s price target on Crispr Therapeutics (CRSP) to $30 from $45 and keeps an Underweight rating on the shares. The ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...

Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...